PRE-CLINICAL DRUG DEVELOPMENT - RATIONALE AND METHODS

被引：0

|

作者：

VENDITTI, JM ^{[1
]}

机构：

[1] NCI,DIV CANC TREATMENT,PROGRAM DEV THERAPEUT,DRUG EVALUAT BRANCH,BETHESDA,MD 20205

来源：

SEMINARS IN ONCOLOGY | 1981年 / 8卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：349 / 361

页数：13

相关论文

共 50 条

[1] Positron Emitting Tracers in Pre-Clinical Drug Development
Fernandes, E.
Barbosa, Z.
Clemente, G.
Alves, F.
Abrunhosa, A. J.
CURRENT RADIOPHARMACEUTICALS, 2012, 5 (02) : 90 - 98
[2] Pre-clinical abuse testing applications in drug development
Randall-Thompson, Jovita
Klein, Michael
DRUG AND ALCOHOL DEPENDENCE, 2017, 171 : E173 - E173
[3] The rationale for and pre-clinical results of chondroitinase ABC in chemonucleolysis
Brown, MD
NEW DEVELOPMENTS IN GLYCOMEDICINE, 2001, 1223 : 171 - 176
[4] Hepatotoxicity in drug development: clinical control, early signals and pre-clinical prediction
Steinmann, G. G.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2007, 101 (05) : 365 - 365
[5] PRE-CLINICAL DEVELOPMENT OF DRUGS
STANDEN, OD
MEDICAL JOURNAL OF ZAMBIA, 1977, 11 (02) : 49 - 52
[6] PRE-CLINICAL DEVELOPMENT OF OXAMNIQUINE
FOSTER, R
REVISTA BRASILEIRA DE MEDICINA, 1977, 34 : 28 - &
[7] Pre-clinical study of the drug Izatizon
Mikitenko, Nina
Potopalskyy, Anatoliy
Zaika, Leonid
Bolsunova, Olga
Karpov, Oleksandr
UKRAINIAN FOOD JOURNAL, 2013, 2 (04) : 535 - 541
[8] PRE-CLINICAL TESTING OF DRUG SAFETY
不详
WHO CHRONICLE, 1967, 21 (02) : 62 - &
[9] Systematic design of a targeted organometallic antitumor drug in pre-clinical development
Dyson, Paul J.
CHIMIA, 2007, 61 (11) : 698 - 703
[10] Safety pharmacology in and for Africa: Establishment of the pre-clinical drug development platform
Guth, Brian D.
Grobler, Anne
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2018, 93 : 26 - 28

← 1 2 3 4 5 →